S-1/A Filing

Processa Pharmaceuticals, Inc. CIK: 1533743 None 2018

Filing Information

Form Type	S-1/A
Accession Number	`0001493152-18-014282`
Period End Date	20180630
Filing Date	20181009
Fiscal Year	2018
Fiscal Period	N/A
XBRL Instance	pcsa-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 118 Income Statement 101 Cash Flow Statement 124 Stockholders Equity 35

Balance Sheet 118 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.07M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.85M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$715.08K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.85M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Certificates of deposit	`CertificatesOfDepositAtCarryingValue`	$1.02M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Certificates of deposit	`CertificatesOfDepositAtCarryingValue`	-	USD	Point-in-time
Certificates of deposit	`CertificatesOfDepositAtCarryingValue`	$496.20K	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$62.71K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	-	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$56.51K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Vendor deposit	`VendorDepositCurrent`	$227.66K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	43.26M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Vendor deposit	`VendorDepositCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.75M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.27M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	38.67M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$41.45K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$18.15K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$83.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.75M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.27M	shares	Point-in-time
Notes receivable	`AccountsAndNotesReceivableNet`	$107.49K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	38.67M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$2.95M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$2.34M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.59M	USD	Point-in-time
Software	`CapitalizedComputerSoftwareGross`	$15.33K	USD	Point-in-time
Software	`CapitalizedComputerSoftwareGross`	$19.74K	USD	Point-in-time
Software	`CapitalizedComputerSoftwareGross`	$19.74K	USD	Point-in-time
Equipment	`MachineryAndEquipmentGross`	$9.33K	USD	Point-in-time
Equipment	`MachineryAndEquipmentGross`	$8.45K	USD	Point-in-time
Equipment	`MachineryAndEquipmentGross`	$9.33K	USD	Point-in-time
Total Cost	`PropertyPlantAndEquipmentGross`	$29.07K	USD	Point-in-time
Total Cost	`PropertyPlantAndEquipmentGross`	$23.77K	USD	Point-in-time
Total Cost	`PropertyPlantAndEquipmentGross`	$29.07K	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$3.25K	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$7.47K	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.38K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.39K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$25.82K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$21.60K	USD	Point-in-time
Security deposit	`DepositsAssetsNoncurrent`	$5.54K	USD	Point-in-time
Security deposit	`DepositsAssetsNoncurrent`	$5.54K	USD	Point-in-time
Security deposit	`DepositsAssetsNoncurrent`	$5.54K	USD	Point-in-time
Intangible asset, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangible asset, net of accumulated amortization	`IntangibleAssetsNetExcludingGoodwill`	$10.82M	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$10.82M	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$5.54K	USD	Point-in-time
Total Other Assets	`OtherAssetsNoncurrent`	$5.54K	USD	Point-in-time
Total Assets	`Assets`	$14.44M	USD	Point-in-time
Total Assets	`Assets`	$2.98M	USD	Point-in-time
Total Assets	`Assets`	$2.36M	USD	Point-in-time
Senior convertible notes, net of debt issuance costs	`SeniorNotesCurrent`	-	USD	Point-in-time
Senior convertible notes, net of debt issuance costs	`SeniorNotesCurrent`	$2.45M	USD	Point-in-time
Senior convertible notes, net of debt issuance costs	`SeniorNotesCurrent`	$224.06K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$11.14K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	-	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$35.69K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$14.59K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$50.69K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$251.40K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$436.00	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$95.00	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.12K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$83.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$64.43K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$161.91K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$97.69K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$649.63K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.60M	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$3.32K	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	-	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$9.96K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.48M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.61M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.13M	USD	Point-in-time
Total Liabilities	`Liabilities`	$97.69K	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES - SEE NOTE	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES - SEE NOTE	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES - SEE NOTE	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.0001, 10,000,000 shares authorized; zero shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001, 10,000,000 shares authorized; zero shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.0001, 10,000,000 shares authorized; zero shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, value	`CommonStockValue`	$3.17K	USD	Point-in-time
Common stock, value	`CommonStockValue`	$3.87K	USD	Point-in-time
Common stock, value	`CommonStockValue`	$3.53K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$19.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.23M	USD	Point-in-time
Subscription receivable	`CommonStockSharesSubscriptions`	$1.80M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-3.86M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$-85.70K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$2.27M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$11.31M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$373.16K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$14.44M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$2.98M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$2.36M	USD	Point-in-time

Income Statement 101 line items

Line Item	Tag	Value	Unit	Period
Research and development costs	`ResearchAndDevelopmentExpense`	$1.08M	USD	1 Quarter
Research and development costs	`ResearchAndDevelopmentExpense`	$160.87K	USD	1 Quarter
Research and development costs	`ResearchAndDevelopmentExpense`	$311.16K	USD	2 Qtrs
Research and development costs	`ResearchAndDevelopmentExpense`	$1.87M	USD	2 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$192.76K	USD	2 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$350.58K	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$119.47K	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$853.92K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.92M	USD	Annual
Total operating expenses	`OperatingExpenses`	$712.85K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.43M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$233.94K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$236.22K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.80M	USD	Annual
Total operating expenses	`OperatingExpenses`	$575.28K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$829.06K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$503.92K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$575.31K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$280.96K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$280.33K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.72M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-1.80M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-2.72M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-1.43M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-1.92M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-280.33K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-503.92K	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$58.31K	USD	1 Quarter
Interest expense	`InterestExpense`	$59.06K	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$59.06K	USD	Annual
Interest expense	`InterestExpense`	$146.05K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$3.39K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$3.71K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.68K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.89K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$5.18K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$4.45K	USD	Annual
Total other income (expense)	`OtherOperatingIncomeExpenseNet`	$1.89K	USD	1 Quarter
Total other income (expense)	`OtherOperatingIncomeExpenseNet`	$-142.35K	USD	2 Qtrs
Total other income (expense)	`OtherOperatingIncomeExpenseNet`	$3.39K	USD	2 Qtrs
Total other income (expense)	`OtherOperatingIncomeExpenseNet`	$-55.63K	USD	1 Quarter
Total other income (expense)	`OtherOperatingIncomeExpenseNet`	$-53.88K	USD	Annual
Total other income (expense)	`OtherOperatingIncomeExpenseNet`	$4.45K	USD	Annual
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-500.54K	USD	2 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.48M	USD	1 Quarter
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.86M	USD	2 Qtrs
Net Loss Before Income Tax Benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-278.44K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-559.32K	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax benefit	`IncomeTaxExpenseBenefit`	$-277.78K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-574.41K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-711.57K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-280.95K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.86M	USD	Annual
Net Loss	`NetIncomeLoss`	$-827.37K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-232.44K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-278.44K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-234.34K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.92M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.21M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-500.54K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-633.86K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.30M	USD	2 Qtrs
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	2 Qtrs
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	Annual
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	Annual
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net Loss per Common Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	2 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	36.62M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.87M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.75M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	32.60M	shares	Annual
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.75M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	29.32M	shares	Annual
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	35.12M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.75M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	35.95M	shares	2 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.75M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.87M	shares	1 Quarter
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.75M	shares	2 Qtrs
Weighted Average Common Shares Used to Compute Net Loss Applicable to Common Shares - Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	31.75M	shares	1 Quarter

Cash Flow Statement 124 line items

Line Item	Tag	Value	Unit	Period
Common stock, shares transferred	`BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued`	2.09M	shares	2 Qtrs
Common stock, shares transferred	`BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued`	31.75M	shares	Point-in-time
Net Loss	`NetIncomeLoss`	$-574.41K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-711.57K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-280.95K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.86M	USD	Annual
Net Loss	`NetIncomeLoss`	$-827.37K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-232.44K	USD	1 Quarter
Conversion of senior convertible debt, value	`ConversionOfSeniorConvertibleDebtValue`	$2.35M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-278.44K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-234.34K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.92M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.21M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-500.54K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-633.86K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.30M	USD	2 Qtrs
Accrued interest converted into shares of common stock	`AccruedInterestConvertedIntoSharesOfCommonStock`	1.21M	shares	2 Qtrs
Depreciation	`Depreciation`	$1.86K	USD	Annual
Depreciation	`Depreciation`	$4.22K	USD	2 Qtrs
Depreciation	`Depreciation`	$1.38K	USD	Annual
Depreciation	`Depreciation`	$933.00	USD	2 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$222.56K	USD	2 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	-	USD	2 Qtrs
Amortization of intangible asset	`AmortizationOfIntangibleAssets`	$197.12K	USD	1 Quarter
Deferred income tax (benefit) expense	`DeferredIncomeTaxExpenseBenefit`	$-559.32K	USD	2 Qtrs
Deferred income tax (benefit) expense	`DeferredIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$23.37K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$61.13K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	-	USD	2 Qtrs
Accrued interest on investments	`DebtInstrumentIncreaseAccruedInterest`	$471.00	USD	2 Qtrs
Accrued interest on investments	`DebtInstrumentIncreaseAccruedInterest`	$201.00	USD	2 Qtrs
Impairment of software costs	`ImpairmentOfSoftwareCosts`	$15.33K	USD	Annual
Impairment of software costs	`ImpairmentOfSoftwareCosts`	-	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInPrepaidExpense`	$16.28K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInPrepaidExpense`	$23.30K	USD	Annual
Prepaid expenses and other	`IncreaseDecreaseInPrepaidExpense`	$42.07K	USD	2 Qtrs
Prepaid expenses and other	`IncreaseDecreaseInPrepaidExpense`	$511.00	USD	2 Qtrs
Vendor deposit	`IncreaseDecreaseInDeposits`	-	USD	2 Qtrs
Vendor deposit	`IncreaseDecreaseInDeposits`	$227.66K	USD	2 Qtrs
Vendor deposit	`IncreaseDecreaseInDeposits`	$227.66K	USD	Annual
Vendor deposit	`IncreaseDecreaseInDeposits`	$-227.66K	USD	Annual
Security deposit	`IncreaseDecreaseInSecurityDeposits`	$-5.54K	USD	Annual
Security deposit	`IncreaseDecreaseInSecurityDeposits`	-	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$84.92K	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	-	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	-	USD	2 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$35.69K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.71K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$9.99K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.23K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$200.71K	USD	2 Qtrs
Due from related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-6.88K	USD	2 Qtrs
Due from related parties	`IncreaseDecreaseInDueFromRelatedParties`	$69.38K	USD	Annual
Due from related parties	`IncreaseDecreaseInDueFromRelatedParties`	$7.82K	USD	2 Qtrs
Due from related parties	`IncreaseDecreaseInDueFromRelatedParties`	$62.37K	USD	Annual
Accrued rent liability	`IncreaseDecreaseInAccruedRentLiability`	$13.28K	USD	Annual
Accrued rent liability	`IncreaseDecreaseInAccruedRentLiability`	-	USD	Annual
Accrued rent liability	`IncreaseDecreaseInAccruedRentLiability`	$9.96K	USD	2 Qtrs
Accrued rent liability	`IncreaseDecreaseInAccruedRentLiability`	-	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$75.79K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-39.83K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-76.02K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$90.84K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-355.93K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.23M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.16M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.65M	USD	Annual
Proceeds from (purchase of) certificates of deposit	`PaymentsForProceedsFromDepositOnLoan`	$-1.02M	USD	Annual
Proceeds from (purchase of) certificates of deposit	`PaymentsForProceedsFromDepositOnLoan`	$1.02M	USD	Annual
Proceeds from (purchase of) certificates of deposit	`PaymentsForProceedsFromDepositOnLoan`	$496.00K	USD	2 Qtrs
Proceeds from (purchase of) certificates of deposit	`PaymentsForProceedsFromDepositOnLoan`	-	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.77K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$882.00	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.62K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Cash received in a reverse acquisition transaction	`CashReceivedInReverseAcquisitionTransaction`	$-6.28K	USD	Annual
Cash received in a reverse acquisition transaction	`CashReceivedInReverseAcquisitionTransaction`	-	USD	Annual
Acquisition of intangible asset	`PaymentsToAcquireIntangibleAssets`	$1.78K	USD	2 Qtrs
Acquisition of intangible asset	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-497.78K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.04M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-882.00	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.00M	USD	Annual
Net Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.86M	USD	2 Qtrs
Net Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.27M	USD	Annual
Net Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Transaction costs incurred on Senior Convertible Notes	`ProceedsFromUnsecuredNotesPayable`	$-4.74K	USD	2 Qtrs
Transaction costs incurred on Senior Convertible Notes	`ProceedsFromUnsecuredNotesPayable`	-	USD	Annual
Transaction costs incurred on Senior Convertible Notes	`ProceedsFromUnsecuredNotesPayable`	-	USD	2 Qtrs
Transaction costs incurred on Senior Convertible Notes	`ProceedsFromUnsecuredNotesPayable`	$2.58M	USD	Annual
Payment of placement agent and legal fees associated with clinical funding commitment	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Payment of placement agent and legal fees associated with clinical funding commitment	`ProceedsFromPaymentsForOtherFinancingActivities`	$117.34K	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$154.80K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.27M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.73M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.43M	USD	Annual
NET DECREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-356.81K	USD	2 Qtrs
NET DECREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.02K	USD	2 Qtrs
NET DECREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.07M	USD	Annual
NET DECREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.78M	USD	Annual
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	-	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$1.07M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$2.85M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.07M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$2.85M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$715.08K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$2.85M	USD	Point-in-time
Recognize exclusive license intangible asset acquired from CoNCERT	`RecognizeExclusiveLicenseIntangibleAssetAcquired`	-	USD	2 Qtrs
Recognize exclusive license intangible asset acquired from CoNCERT	`RecognizeExclusiveLicenseIntangibleAssetAcquired`	$-11.04M	USD	2 Qtrs
Recognize deferred tax liability for basis difference for intangible asset	`RecognizationOfDeferredTaxLiability`	$3.04M	USD	2 Qtrs
Recognize additional paid-in capital for consideration paid from the transfer of 2,090,301 common shares of Processa owned by Promet to CoNCERT	`PaymentOfAdditionalPaidInCapitalForConsideration`	-	USD	2 Qtrs
Recognize additional paid-in capital for consideration paid from the transfer of 2,090,301 common shares of Processa owned by Promet to CoNCERT	`PaymentOfAdditionalPaidInCapitalForConsideration`	$8.00M	USD	2 Qtrs
Cash paid for intangible asset acquired from CoNCERT	`CashPaidForIntangibleAssetAcquired`	-	USD	2 Qtrs
Cash paid for intangible asset acquired from CoNCERT	`CashPaidForIntangibleAssetAcquired`	-	USD	2 Qtrs
Conversion of $2,350,000 of Senior Convertible Debt and related accrued interest into 1,206,245 shares of common stock and warrants	`ConversionOfSeniorConvertibleDebtAndRelatedAccruedInterestIntoSharesOfCommonStockAndWarrants`	$2.40M	USD	2 Qtrs
Conversion of $2,350,000 of Senior Convertible Debt and related accrued interest into 1,206,245 shares of common stock and warrants	`ConversionOfSeniorConvertibleDebtAndRelatedAccruedInterestIntoSharesOfCommonStockAndWarrants`	-	USD	2 Qtrs
Common stock and stock purchase warrants issued in connection with a clinical trial funding commitment	`CommonStockAndStockPurchaseWarrantsIssuedInConnectionWithClinicalTrialFundingCommitment`	$1.80M	USD	2 Qtrs
Common stock and stock purchase warrants issued in connection with a clinical trial funding commitment	`CommonStockAndStockPurchaseWarrantsIssuedInConnectionWithClinicalTrialFundingCommitment`	-	USD	2 Qtrs
Note receivable related to the sale of common stock and stock purchase warrants	`NoteReceivableRelatedToSaleOfCommonStockAndStockPurchaseWarrants`	-	USD	2 Qtrs
Note receivable related to the sale of common stock and stock purchase warrants	`NoteReceivableRelatedToSaleOfCommonStockAndStockPurchaseWarrants`	$107.49K	USD	2 Qtrs

Stockholders Equity 35 line items

Line Item	Tag	Value	Unit	Period
Issuance of Common Stock, $0.0001 Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Issuance of Common Stock, $0.0001 Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Issuance of Common Stock, $0.0001 Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares exchanged	`BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued`	2.09M	shares	2 Qtrs
Common stock, shares exchanged	`BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued`	31.75M	shares	Point-in-time
Conversion of stock, costs	`ConversionOfStockNetOfCosts`	$4.74K	USD	2 Qtrs
Issuance of common stock units for cash, cost	`PaymentsOfStockIssuanceCosts`	$219.95K	USD	2 Qtrs
Issuance of common stock units for a future research funding commitment, cost	`IssuanceOfCommonStockUnitsForFutureResearchFundingCommitmentCost`	$117.34K	USD	2 Qtrs
Balance	`StockholdersEquity`	$-85.70K	USD	Point-in-time
Balance	`StockholdersEquity`	$2.27M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$373.16K	USD	Point-in-time
Issuance of Common Stock, $0.0001 Par Value/Share	`StockIssuedDuringPeriodValueNewIssues`	$4.27M	USD	Annual
Fair value of Heatwurx net liabilities obtained in reverse acquisition	`FairValueOfNetLiabilitiesObtainedInReverseAcquisition`	$-37.75K	USD	Annual
Recognize the fair value of exclusive license intangible asset acquired from CoNCERT in exchange for 2,090,301 common shares of Processa owned by Promet	`FairValueOfExclusiveLicenseIntangibleAssetAcquired`	8.00M	shares	2 Qtrs
Conversion of Senior convertible notes for common stock and stock purchase warrants, net of costs of $4,742	`StockIssuedDuringPeriodValueConversionOfUnits`	$2.39M	USD	2 Qtrs
Issuance of common stock units for cash, net of costs of $219,954	`StockIssuedDuringPeriodValueNewIssuesOne`	$2.96M	USD	2 Qtrs
Issuance of common stock units for a future research funding commitment, net of costs of $117,339	`StockIssuedDuringPeriodValueOther`	$-117.34K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-574.41K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-711.57K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-280.95K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.86M	USD	Annual
Net Loss	`NetIncomeLoss`	$-827.37K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-232.44K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-278.44K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-234.34K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.92M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.21M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-500.54K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-633.86K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.30M	USD	2 Qtrs
Balance	`StockholdersEquity`	$-85.70K	USD	Point-in-time
Balance	`StockholdersEquity`	$2.27M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.31M	USD	Point-in-time
Balance	`StockholdersEquity`	$373.16K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.